Home > Insider Trading > Filing (0000939767-16-000288)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
939767	Exelixis Inc.	EXEL	Services-Commercial Physical & Biological Research (8731)	043257395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202102	A George Scangos	C/O Exelixis, Inc. 210 E. Grand Ave. South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-12-05	357,976	$8.99	1,668,186	No	4	M	Direct
Common Stock	Disposition	2016-12-05	204,718	$17.81	1,463,468	No	4	S	Direct
Common Stock	Acquisiton	2016-12-07	356	$8.99	1,463,824	No	4	M	Direct
Common Stock	Disposition	2016-12-07	176	$17.90	1,463,648	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2016-12-05	357,976	$0.00	357,976	$8.99
Common Stock	Option (right to buy)	Disposition	2016-12-07	356	$0.00	356	$8.99

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
356	2007-12-08	2016-12-07	No	4	M	Direct
0	2007-12-08	2016-12-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,963	Indirect	By Trust (JS)
Common Stock	8,963	Indirect	By Trust (KS)
Common Stock	5,669	Indirect	By 401(k) Plan

Footnotes

Includes 1,596 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.45 to $18.00. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
Represents 5,669 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 2, 2016.
The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became exercisable as to 100,000 shares on December 8, 2007, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the original grant date (December 8, 2006). The option ceased vesting on July 15, 2010, in connection with the Reporting Person's resignation as President and Chief Executive Officer of Exelixis, Inc., at which time the option was exercisable as to as to 358,332 shares of Exelixis, Inc. Common Stock.